UF Health Enrolls First Patient in Clinical Trial Aimed at Creating New Treatment for COVID-19
University of Florida Health has enrolled its first patient in a clinical trial for Regeneron Pharmaceuticals’ monoclonal antibody cocktail to treat COVID-19, a therapy that might neutralize the coronavirus and prevent it from infecting cells. UF Health is one of the hundreds of medical centers internationally participating in the blinded, placebo-controlled, randomized clinical trial to […]